68Ga-RM26-RGD

N/A

Report date: 2025/11/26 17:57:27

Base Information

Drug Name68Ga-RM26-RGD
Drug Alias Name68Ga-RM26-RGD68Ga-DOTA-RM26-RGD68Ga-labeled DOTA-RM26-RGD
ClassificationRadiation-emitting products > Nuclides > Gallium > 68GaDiagnostic agent (In vivo) > Radionuclide Imaging agentRadiation-emitting products > Radionuclide Drug Conjugates +[4] 
Mechanisms of ActionIntegrin bindersGastrin releasing peptide receptor binders
TargetsIntegrinGastrin releasing peptide receptor
Therapy Area/IndicationsContrast agentsProstatic NeoplasmsBrain Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesPeking Union Medical College Hospital
China Registration ClassN/A

Develop Information

Active CompaniesPeking Union Medical College Hospital
Inactive CompaniesN/A
Active IndicationsContrast agentsProstatic NeoplasmsBrain Neoplasms +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A